The Immunology of Hormone Receptor Positive Breast Cancer

Immune checkpoint blockade (ICB) has revolutionized the treatment of cancer patients. The main focus of ICB has been on reinvigorating the adaptive immune response, namely, activating cytotoxic T cells. ICB has demonstrated only modest benefit against advanced breast cancer, as breast tumors typical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Goldberg, Jonathan, Pastorello, Ricardo G., Vallius, Tuulia, Davis, Janae, Cui, Yvonne Xiaoyong, Agudo, Judith, Waks, Adrienne G., Keenan, Tanya, McAllister, Sandra S., Tolaney, Sara M., Mittendorf, Elizabeth A., Guerriero, Jennifer L.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8202289/
https://ncbi.nlm.nih.gov/pubmed/34135901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.674192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars